ALEXANDRIA, Va., July 3 -- United States Patent no. 12,344,610, issued on July 1, was assigned to Maze Therapeutics Inc. (South San Francisco, Calif.).
"APOL1 inhibitors and methods of use" was invented by Patrick Sang Tae Lee (Walnut Creek, Calif.), Todd Jonathan August Ewing (Walnut Creek, Calif.), Adam Neil Reid (San Francisco), Christopher Joseph Sinz (Walnut Creek, Calif.), Birong Zhang (Union City, Calif.), Sarah M. Bronner (Oakland, Calif.), David John Morgans Jr. (Los Altos, Calif.), Maarten Hoek (Belmont, Calif.), Victoria Anne Assimon (San Francisco), Chris Ziebenhaus (San Francisco) and Alexander Wayne Schammel (San Diego).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds...